Philadelphia-based Thomas Jefferson University's venture capital arm, Jefferson Innovation, is focusing on biotech and medical device investments.
Here are the 16 companies in Jefferson Innovation's portfolio, according to its website:
- BioVaxys
- Bound Therapeutics
- BrachyThermix
- Capillary Biomedical
- Circalux
- Clementia
- Conatus Pharmaceuticals
- Immunome
- Imvax
- MTTI
- NuView Life Sciences
- RTM Vital Signs
- Sonogen Medical
- Sillajen
- Targeted Diagnostics & Therapeutics
- Xilio Therapeutics